Researchers identify medulloblastoma molecular groups using noninvasive MRI spectroscopy

Research by Stefan Blüml, Ph.D., and colleagues investigates the use of in vivo proton magnetic resonance spectroscopy (¹H-MRS) to identify medulloblastoma molecular subgroups before surgery, a noninvasive alternative to surgical tumor sampling that could help support treatment planning at an earlier stage. The study is published in the journal Neuro-Oncology.

≈